A structured clinical interview was used to evaluate lifetime PTSD history. The PTSD symptom checklist was used to evaluate current PTSD symptoms, and median follow-up was 4.9 years.

The new drug has already passed Phase 1 safety trials in humans, making it a "strong candidate" for future PTSD treatments.

Post-traumatic stress disorder (PTSD) is a mental health disorder triggered by traumatic experiences such as accidents, ...

Unmarried non-Hispanic white males who are diagnosed with cancers that contribute most to mortality Prolonged exposure therapy reduced PTSD symptom severity more than minimal-contact control ...

An FDA committee's "no" vote on an MDMA-assisted treatment for PTSD is an opportunity to rally support for better-funded, well-controlled clinical trials for PTSD therapies.